Warning: Declaration of tie_mega_menu_walker::start_el(&$output, $item, $depth, $args, $id = 0) should be compatible with Walker_Nav_Menu::start_el(&$output, $item, $depth = 0, $args = Array, $id = 0) in /home5/artechne/public_html/hdom/wp-content/themes/sahifa/functions/theme-functions.php on line 1965
hdom.org | Oman's Huntington Disease Association | Page 2

Oman Huntington Disease Association will participate in the EHDN Conference in Barcelona, Sept 19-21, 2014

For the first time a Middle East patients’ Association will participate in  the European Huntington Disease Network Conference. The International Huntington Association (IHA), the European Huntington Association (EHA), the European Huntington Disease Network (EHDN) welcomed the Oman Huntington Disease Association in joining the international scientific community and the international patients’ community in Barcelona. Thanks to our partner organization LIRH – Italian ... Read More »

Huntington Disease, May 21st, 2014: the first two patients recruited in Europe in the international drug trial Pride-HD are from an Italian Centre

22/05/2014 As reported in April 24, 2014 Teva’s official note, “The Pride-HD Study, is a phase II, dose-finding, randomized, parallel-group, double-blind, placebo-controlled study, that aims to enroll approximately 400 patients at 30 sites across the globe and evaluate the safety and efficacy of pridopidine 45 mg, 67.5 mg, 90 mg, and 112.5 mg twice daily (bid) versus placebo for symptomatic ... Read More »

Pride-HD Study Enrolling Patients Globally to Further Evaluate Pridopidine for the Symptomatic Treatment of Huntington’s Disease

Study initiation represents significant milestone for patients with a disease with limited effective treatment options JERUSALEM–(BUSINESS WIRE)–Apr. 24, 2014– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today enrollment of the first patient in The Pride-HD study, a phase II, randomized, double-blind, placebo-controlled global study designed to evaluate the impact of pridopidine, an investigational medication, on motor impairment in patients with ... Read More »

Cross Country for Huntington Disease

“In April this year I will be riding my bike for the European Huntington federation; a cycling tour through Europe dedicated to a disease which has wrecked havoc in my family. What it means to my family is the untimely death of my grandmother, the deterioration and the eventual death of my aunt Ria and at present the decline of ... Read More »